Abiopharma

Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Fortrea Holdings Inc.(FTRE) Shareholders

Curaleaf to Report Second Quarter 2025 Financial and Operational Results

New Form 8-K - Monogram Technologies Inc. Filed: 2025-07-08 AccNo: 0001104659-25-066301 Size: 214 KB Item 3.03: Material Modifications to Rights of Security Holders Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

Medtronic announces appointment of MiniMed chief financial officer ahead of intended separation into standalone company

Citius Pharmaceuticals, Inc. - Citius Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement

Tivic Shareholders Approve Key Proposals in Support of Strategic Transformation; Lisa Wolf Appointed Permanent CFO

A New Press Release from Oncolytics Biotech, Inc

New Form 8-K - QHSLab, Inc. Filed: 2025-07-08 AccNo: 0001641172-25-018099 Size: 271 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

New Form 8-K - OneMedNet Corp Filed: 2025-07-08 AccNo: 0001641172-25-018100 Size: 3 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

New Form 8-K - Microbot Medical Inc. Filed: 2025-07-08 AccNo: 0001641172-25-018098 Size: 238 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

Conduit Engages Consultant to Explore Cryptocurrency Reserve Strategy

Microbot Medical® to Open Inaugural Endovascular Robotics Session at the Society of Robotic Surgery Annual Meeting

Calidi Biotherapeutics - Calidi Biotherapeutics Inc. (NYSE American: CLDI) Developing Precision Genetic Medicine Platform for Cancer Treatment

Cardio Diagnostics Enters Into an Agreement with AGEPHA Pharma to Advance Precision Assessment and Management of Inflammation Associated with Coronary Heart Disease

Unicycive Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement